UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Obesity, haemostasis and the fibrinolytic system

Obesity reviews, 2002-05, Vol.3 (2), p.85-101

2002

Volltextzugriff (PDF)

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

International Journal of Obesity, 2006-08, Vol.30 (8), p.1308-1314

2006

Volltextzugriff (PDF)

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

International Journal of Obesity, 2014-07, Vol.38 (7), p.1000-1004

2014

Volltextzugriff (PDF)

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

International Journal of Obesity, 2017-11, Vol.41 (11), p.1615-1620

2017

Volltextzugriff (PDF)

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Diabetologia, 2011-06, Vol.54 (6), p.1273-1290

2011

Volltextzugriff (PDF)

Human leptin: from an adipocyte hormone to an endocrine mediator

European journal of endocrinology, 2000-09, Vol.143 (3), p.293-311

2000

Volltextzugriff (PDF)

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4463-4471

2015

Volltextzugriff (PDF)

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.523-530

2012

Volltextzugriff (PDF)

Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score

Journal of diabetes and its complications, 2016-08, Vol.30 (6), p.1043-1049

2016

Volltextzugriff (PDF)

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

Journal of endocrinological investigation, 2017-11, Vol.40 (11), p.1165-1174

2017

Volltextzugriff (PDF)

Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women

International Journal of Obesity, 2001-05, Vol.25 (5), p.714-720

2001

Volltextzugriff (PDF)

Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight Reduction

Obesity (Silver Spring, Md.), 2000-05, Vol.8 (3), p.270-278

2000

Volltextzugriff (PDF)

Metabolic disregulation in obese adolescents with sleep‐disordered breathing before and after weight loss

Obesity (Silver Spring, Md.), 2013-07, Vol.21 (7), p.1446-1450

2013

Volltextzugriff (PDF)

Efficacy and tolerability of orlistat in the treatment of obesity : a 6-month dose-ranging study

European journal of clinical pharmacology, 1998-04, Vol.54 (2), p.125-132

1998

Volltextzugriff (PDF)

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

International Journal of Obesity, 2001-04, Vol.25 (4), p.496-501

2001

Volltextzugriff (PDF)

Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications

Diabetes & metabolism, 2004-12, Vol.30 (6), p.509-516

2004

Volltextzugriff (PDF)

Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?

Obesity reviews, 2019-02, Vol.20 (2), p.353-363

2019

Volltextzugriff (PDF)

Genetic association between WNT10B polymorphisms and obesity in a Belgian case–control population is restricted to males

Molecular genetics and metabolism, 2012-03, Vol.105 (3), p.489-493

2012

Volltextzugriff (PDF)

Rationale and options for combination therapy in the treatment of Type 2 diabetes

Diabetologia, 2003-03, Vol.46 Suppl 1 (S1), p.M44-M50

2003

Volltextzugriff (PDF)

Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes

Diabetes care, 2000-09, Vol.23 (9), p.1384-1388

2000

Volltextzugriff (PDF)

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes

Diabetes, obesity & metabolism, 2003-05, Vol.5 (3), p.163-170

2003

Volltextzugriff (PDF)

Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus

Alimentary pharmacology & therapeutics, 2002-02, Vol.16 (2), p.281-289

2002

Volltextzugriff (PDF)

New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP‐ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.1164-1166

2006

Volltextzugriff (PDF)

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

The Lancet (British edition), 2000-12, Vol.356 (9248), p.2119-2125

2000

Volltextzugriff (PDF)

Promising new approaches to the management of obesity

Drugs (New York, N.Y.), 2000-07, Vol.60 (1), p.1-9

2000

Volltextzugriff (PDF)

1 – 25 von 289

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(202)
Science & Technology
(191)
Life Sciences & Biomedicine
(187)
Female
(147)
Male
(135)
Endocrinology & Metabolism
(104)
Middle Aged
(100)
Adult
(99)
Biological And Medical Sciences
(82)
Medical Sciences
(79)
Obesity
(78)
Risk Factors
(53)
Diabetes
(52)
Adolescent
(51)
Aged
(51)
Nutrition & Dietetics
(39)
Body Mass Index
(38)
Metabolic Diseases
(35)
Endocrinopathies
(34)
Diabetes Mellitus, Type 2 - Drug Therapy
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Obesity, haemostasis and the fibrinolytic system

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Human leptin: from an adipocyte hormone to an endocrine mediator

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women

Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight Reduction

Metabolic disregulation in obese adolescents with sleep‐disordered breathing before and after weight loss

Efficacy and tolerability of orlistat in the treatment of obesity : a 6-month dose-ranging study

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications

Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?

Genetic association between WNT10B polymorphisms and obesity in a Belgian case–control population is restricted to males

Rationale and options for combination therapy in the treatment of Type 2 diabetes

Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes

Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus

New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP‐ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

Promising new approaches to the management of obesity

Suchergebnisse filtern